blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3092217

EP3092217 - A NOVEL PROCESS FOR PREPARATION OF INDACATEROL OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  01.05.2020
Database last updated on 28.06.2024
FormerGrant of patent is intended
Status updated on  08.01.2020
FormerExamination is in progress
Status updated on  27.07.2018
Most recent event   Tooltip24.11.2023Change: Date of oral proceedings 
24.11.2023Deletion: Despatch of minutes of oral proceedings 
Applicant(s)For all designated states
Davuluri, Ramamohan Rao
11th Floor, 5th Office Level, Plot No. 573A-III
Phoenix IVY Building, Road No. 82, Jubilee Hills
Hyderabad, Telangana 500033 / IN
[2023/07]
Former [2016/46]For all designated states
Davuluri, Ramamohan Rao
Sanali Info Park 'A' Block
Ground Floor 8-2-120/113 Rd. No 2
Banjara Hills
Hyderabad 500 034 / IN
Inventor(s)01 / RAVI, Ponnaiah
No. 3/414 Immanuel Street
Tilak Nagar
Iyer Bunglow
Madurai 625014 / IN
02 / NEELA, Praveen Kumar
Flat No-102
Balaji Enclave
Balaji Park Town
Nizampet Road, Kukatpally
Hyderabad 500072 / IN
03 / BATTHINI, Guruswamy
Flat No-403
Sri Saichandra Residency
Madhavi Nagar
Hyderabad 500074 / IN
04 / VENUGOPALARAO, Narayana
Plot No. 19, Phase-II
Narayana Reddy Colony Post
Opp Pakruthi Vihar Appt
Ameenpur, Medhak District
Hyderabad 502032 / IN
05 / DONGARI, Naresh
S/O Mohan Rao
Kalakova
(Village&Post
Munagala (Mandal) District
Nalagonda 508213 / IN
 [2020/23]
Former [2016/46]01 / RAVI, Ponnaiah
No. 3/414 Immanuel Street
Tilak Nagar
Iyer Bunglow
Madurai 625014 / IN
02 / NEELA, Praveen Kumar
Flat No-102
Balaji Enclave
Balaji Park Town
Nizampet Road, Kukatpally
Hyderabad 500072 / IN
03 / BATTHINI, Guruswamy
Flat No-403
Sri Saichandra Residency
Madhavi Nagar
Hyderabad 500074 / IN
04 / VENUGOPALARAO, Narayana
Plot No. 19 Phase-II
Narayana Reddy Colony Post
Opp Pakruthi Vihar Appt
Ameenpur, Medhak District
Hyderabad 502032 / IN
05 / DONGARI, Naresh
S/O Mohan Rao
Kalakova
(Village&Post
Munagala (Mandal) District
Nalagonda 508213 / IN
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2016/46]Dall'Olio, Christian, et al
INVENTION S.r.l. Via delle Armi, 1
40137 Bologna / IT
Application number, filing date14877661.027.12.2014
[2016/46]
WO2014IN50006
Priority number, dateIN2014CHE11609.01.2014         Original published format: IN 116CH2014
[2017/16]
Former [2016/46]IN2014CHE011609.01.2014
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015104718
Date:16.07.2015
Language:EN
[2015/28]
Type: A2 Application without search report 
No.:EP3092217
Date:16.11.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 16.07.2015 takes the place of the publication of the European patent application.
[2016/46]
Type: B1 Patent specification 
No.:EP3092217
Date:03.06.2020
Language:EN
[2020/23]
Search report(s)International search report - published on:IN03.03.2016
(Supplementary) European search report - dispatched on:EP05.04.2017
ClassificationIPC:C07D215/26, C07F7/18
[2017/18]
CPC:
C07D215/26 (EP,US); C07F7/1804 (EP,US)
Former IPC [2016/46]C07D215/26
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/46]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NEUARTIGES VERFAHREN ZUR HERSTELLUNG VON INDACATEROL ODER DESSEN PHARMAZEUTISCH VERTRÄGLICHEN SALZEN[2016/46]
English:A NOVEL PROCESS FOR PREPARATION OF INDACATEROL OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS[2016/46]
French:NOUVEAU PROCÉDÉ DE PRÉPARATION D'INDACATÉROL OU DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES[2016/46]
Entry into regional phase05.08.2016National basic fee paid 
05.08.2016Search fee paid 
05.08.2016Designation fee(s) paid 
05.08.2016Examination fee paid 
Examination procedure05.08.2016Examination requested  [2016/46]
20.09.2017Amendment by applicant (claims and/or description)
27.07.2018Despatch of a communication from the examining division (Time limit: M04)
20.11.2018Reply to a communication from the examining division
01.04.2019Despatch of a communication from the examining division (Time limit: M04)
30.07.2019Reply to a communication from the examining division
09.01.2020Communication of intention to grant the patent
27.04.2020Fee for grant paid
27.04.2020Fee for publishing/printing paid
27.04.2020Receipt of the translation of the claim(s)
Opposition(s)Opponent(s)01  01.03.2021   
IP2 Patentanwalts GmbH
Schlossstraße 523-525
41238 Mönchengladbach / DE
Opponent's representative
Fabry, Bernd
IP2 Patentanwalts GmbH
Schlossstrasse 523-525
41238 Mönchengladbach / DE
 [2021/14]
13.04.2021Invitation to proprietor to file observations on the notice of opposition
18.08.2021Reply of patent proprietor to notice(s) of opposition
19.09.2022Date of oral proceedings
31.10.2022Despatch of minutes of oral proceedings
02.11.2022Despatch of communication that the patent will be revoked
Appeal following opposition06.01.2023Appeal received No.  T0037/23
06.01.2023Payment of appeal fee
13.03.2023Statement of grounds filed
19.12.2024Date of oral proceedings
Fees paidRenewal fee
19.12.2016Renewal fee patent year 03
04.12.2017Renewal fee patent year 04
14.12.2018Renewal fee patent year 05
23.12.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.12.2014
AL03.06.2020
AT03.06.2020
CY03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
MK03.06.2020
MT03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
IE27.12.2020
LU27.12.2020
BE31.12.2020
CH31.12.2020
LI31.12.2020
[2022/33]
Former [2022/32]HU27.12.2014
AL03.06.2020
AT03.06.2020
CY03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
MK03.06.2020
MT03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
IE27.12.2020
LU27.12.2020
CH31.12.2020
LI31.12.2020
Former [2022/28]HU27.12.2014
AL03.06.2020
AT03.06.2020
CY03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
MT03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
IE27.12.2020
LU27.12.2020
CH31.12.2020
LI31.12.2020
Former [2021/52]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
IE27.12.2020
LU27.12.2020
CH31.12.2020
LI31.12.2020
Former [2021/47]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
IE27.12.2020
LU27.12.2020
Former [2021/46]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
IE27.12.2020
Former [2021/40]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
MC03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
Former [2021/24]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SI03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
Former [2021/21]AL03.06.2020
AT03.06.2020
CZ03.06.2020
DK03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
Former [2021/10]AL03.06.2020
AT03.06.2020
CZ03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SK03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
IS03.10.2020
Former [2021/09]AL03.06.2020
AT03.06.2020
CZ03.06.2020
EE03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
NL03.06.2020
RO03.06.2020
RS03.06.2020
SE03.06.2020
SM03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
Former [2021/04]AL03.06.2020
FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
NL03.06.2020
RS03.06.2020
SE03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
Former [2021/01]FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
RS03.06.2020
SE03.06.2020
BG03.09.2020
NO03.09.2020
GR04.09.2020
Former [2020/51]FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
RS03.06.2020
SE03.06.2020
NO03.09.2020
GR04.09.2020
Former [2020/50]FI03.06.2020
HR03.06.2020
LT03.06.2020
LV03.06.2020
SE03.06.2020
NO03.09.2020
GR04.09.2020
Former [2020/48]FI03.06.2020
LT03.06.2020
SE03.06.2020
NO03.09.2020
Former [2020/47]LT03.06.2020
NO03.09.2020
Documents cited:Search[XPI]WO2014044566  (CRYSTAL PHARMA SAU [ES]) [XP] 3 * page 1, paragraph 1 * * page 9, line 28 - page 10, line 24 *[I] 1,2,4;
 [A]  - ADAM D. HUGHES ET AL, "Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (20110301), vol. 21, no. 5, doi:10.1016/j.bmcl.2011.01.043, ISSN 0960-894X, pages 1354 - 1358, XP055011968 [A] 1 * compound 15 *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2011.01.043
International search[A]WO0075114  (NOVARTIS AG [CH], et al) [A] 1-4 * whole document *;
 [A]WO2013132514  (RAO DAVULURI RAMAMOHAN [IN]) [A] 1-4 * whole document *;
 [PX]WO2014044288  (CRYSTAL PHARMA SA [ES], et al) [PX] 1-4 * whole document *;
 [PX]WO2014154841  (LESVI LABORATORIOS SL [ES]) [PX] 1-4 * whole document *
by applicantUS6878721
 US7534890
 WO0075114
 WO2005123684
 WO2008093188
 WO2013132514
 WO2004087668
 WO2014044566
 WO2014154841
 WO2014044288
    - Biorganic & Medicinal Chemistry Letters, (20110301), vol. 21, no. 5, pages 1354 - 1358
OppositionWO0075114
 WO03042160
 WO2004076422
 WO2013132514
 WO2014044566
 WO2014154841
    - HUGHES et al., "Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules", Bioorg. Med. Chem. Lett., (20110000), vol. 21, no. 5, pages 1354 - 1358, XP055011968

DOI:   http://dx.doi.org/10.1016/j.bmcl.2011.01.043
    - T. W. GREENE et al., Protective Groups in Organic Synthesis, New York, (19990000), pages 76 - 79,127-141, XP055790654
    - MATHRE et al., "A Practical Enantioselective Synthesis of alpha,alpha-Diaryl-2- pyrrolidinemethanol . Preparation and Chemistry of the Corresponding Oxazab- orolidines", J. Org. Chem., (19910000), vol. 56, pages 751 - 762, XP002200364

DOI:   http://dx.doi.org/10.1021/jo00002a049
    - "N-Methyl-2-pyrrolidone", Concise International Chemical Assessment Document 35, Geneva, (20010000), XP055790656
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.